Hinge Health reported nine-month revenue growth of 51%, primarily from existing clients, and net income of 136,217 (in thousands) versus a loss of 560,356 (in thousands).
HNGE · Hinge Health, Inc.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Hinge Health reported Q3 revenue of $235 million, up 52%, and raised 2026 revenue guidance to $879 million to $881 million. Jim Pursley will step down as president at year-end and join the board.
Hinge Health, Inc. reported third-quarter revenue of $235.0 million, up 52% year-over-year, and raised full-year 2026 revenue guidance to between $879 million and $881 million; non-GAAP operating margin guidance is 30% at the midpoint.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY26 earnings call · Aug 4, 2026TL;DR. Hinge Health posted Q2 revenue of $213 million (53% YoY growth) and raised full-year 2026 revenue guidance to $856–$860 million alongside higher operating income guidance, while announcing a $105 million cash acquisition of Cylinder Health to enter GI care and a $300 million increase to its share repurchase authorization.
- + Q2 revenue grew 53% YoY to $213 million, well above the $200–$202 million guidance range.
- + LTM calculated billings grew 52% YoY to $862 million, supporting continued revenue momentum.
- + Non-GAAP operating margin expanded to 29% from 19% a year ago and free cash flow tripled YoY to $100 million.
- + Yield is now expected to reach ~4.45% for the year, driving durable billings and revenue outperformance.
- + Migraine program launched within the quarter has gained 450+ clients covering more than 5 million lives.
- + Hinge Health signed a definitive agreement to acquire Cylinder Health for $105 million in cash to enter GI care.
- − Cylinder Health acquisition will deploy $105 million in cash and bring near-term losses that must be integrated over the next year or two.
- − GAAP gross margin of 86% reflected benefit from a one-time tariff refund providing about 100 basis points of boost, which is not expected to repeat.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Free cash flow non-GAAP | 253.77M | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Free cash flow margin non-GAAP | 40% | Nine Months Ended September 30, 2026 | — |
|
|
|||
| LTM calculated billings | 960.3M | as of September 30, 2026 | — |
| Non-GAAP gross margin non-GAAP | 87% | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Non-GAAP gross profit non-GAAP | 546.9M | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Non-GAAP income from operations non-GAAP | 184.89M | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Non-GAAP operating margin non-GAAP | 29% | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Number of clients | 3,270 | as of September 30, 2026 | — |
| Operating cash flow margin | 41% | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Non-GAAP diluted net income per share non-GAAP | $0.59 | Q2 2026 | — |
| Non-GAAP net income attributable to common stockholders, diluted non-GAAP | $49.15M | Three Months Ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP GAAP net income (loss) attributable to common stockholders, diluted $43.13M
+$19.09M Stock-based compensation expense
+$1.32M Employer payroll tax expense related to stock-based compensation
+$224K Amortization of intangible assets
+$440K Acquisition-related expenses
-$14.98M Income tax effect of non-GAAP adjustments
-$78K Other dilutive
= Non-GAAP net income attributable to common stockholders, diluted $49.15M
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HNGE
this stock
Hinge Health, Inc.
|
$9.38B | +148.4% | +50.6% | 56.3 | 6.1% |
|
VEEV
Veeva Systems Inc
|
$48.82B | +35.1% | +28.1% | 49.4 | 2.4% |
|
PMDIY
Pro Medicus Ltd.
|
$14.81B | -14.6% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$14.17B | +90.1% | +28.2% | 38.7 | 5.8% |
|
TEM
Tempus AI, Inc.
|
$13.06B | +21.3% | +83.4% | — | 13.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 9, 2026
- This year
- 17
Hinge Health reported nine-month revenue growth of 51%, primarily from existing clients, and net income of 136,217 (in thousands) versus a loss of 560,356 (in thousands).
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HNGE | -0.3% | +16.4% | +117.8% | +0.9% | +148.4% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -2.9% | +17.5% | +117.3% | +1.1% | +137.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.